1. Home
  2. TOVX vs NXRT Comparison

TOVX vs NXRT Comparison

Compare TOVX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
    SELLHOLDBUYas of a day ago
  • NXRT
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • TOVX 2001
  • NXRT 2014
  • Country
  • TOVX United States
  • NXRT United States
  • Employees
  • TOVX N/A
  • NXRT N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • NXRT Real Estate Investment Trusts
  • Sector
  • TOVX Health Care
  • NXRT Real Estate
  • Exchange
  • TOVX Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • TOVX 3.2M
  • NXRT 1.2B
  • IPO Year
  • TOVX 2006
  • NXRT N/A
  • Fundamental
  • Price
  • TOVX $1.47
  • NXRT $38.70
  • Analyst Decision
  • TOVX Strong Buy
  • NXRT Buy
  • Analyst Count
  • TOVX 1
  • NXRT 5
  • Target Price
  • TOVX $6.00
  • NXRT $49.00
  • AVG Volume (30 Days)
  • TOVX 1.0M
  • NXRT 132.0K
  • Earning Date
  • TOVX 11-12-2024
  • NXRT 02-18-2025
  • Dividend Yield
  • TOVX N/A
  • NXRT 5.25%
  • EPS Growth
  • TOVX N/A
  • NXRT 54.64
  • EPS
  • TOVX N/A
  • NXRT 1.77
  • Revenue
  • TOVX N/A
  • NXRT $264,974,000.00
  • Revenue This Year
  • TOVX N/A
  • NXRT N/A
  • Revenue Next Year
  • TOVX N/A
  • NXRT $0.54
  • P/E Ratio
  • TOVX N/A
  • NXRT $22.09
  • Revenue Growth
  • TOVX N/A
  • NXRT N/A
  • 52 Week Low
  • TOVX $1.14
  • NXRT $28.20
  • 52 Week High
  • TOVX $17.00
  • NXRT $48.37
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 49.94
  • NXRT 26.43
  • Support Level
  • TOVX $1.58
  • NXRT $40.77
  • Resistance Level
  • TOVX $1.79
  • NXRT $42.14
  • Average True Range (ATR)
  • TOVX 0.18
  • NXRT 1.20
  • MACD
  • TOVX 0.03
  • NXRT -0.38
  • Stochastic Oscillator
  • TOVX 35.11
  • NXRT 5.39

Stock Price Comparison Chart: TOVX vs NXRT

TOVX
NXRT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100TOVX VS NXRT

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use